List of works - Jie Jin

A novel alkylating deacetylase inhibitor molecule EDO-S101 in combination with cytarabine synergistically enhances apoptosis of acute myeloid leukemia cells

scientific article published on 01 August 2019

Aberrant expression of NLRP3, NLRC4 and NLRP6 inflammasomes in patients with primary immune thrombocytopenia

scientific article published on 19 February 2019

Abivertinib synergistically strengthens the anti-leukemia activity of venetoclax in acute myeloid leukemia in a BTK-dependent manner

scientific article published on 10 June 2020

An oral, chemotherapy-free regimen (dasatinib plus prednisone) as induction and consolidation for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia

scientific article published on 21 April 2020

Author Correction: Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia.

scientific article published on 9 February 2018

Bortezomib-based therapy for transplant-ineligible East Asian patients with newly diagnosed mantle-cell lymphoma

article

CAG regimen for refractory or relapsed adult T-cell acute lymphoblastic leukemia: A retrospective, multicenter, cohort study

scientific article published on 03 June 2020

CDKN2A deletions are associated with poor outcomes in 101 adults with T-cell acute lymphoblastic leukemia

scientific article published on 11 December 2020

Clinical Significance of Prognostic Nutritional Index for Patients with Diffuse Large B-cell Lymphoma

scientific article published on 29 December 2018

Clinical and biological characteristics of acute myeloid leukemia with 20-29% blasts: a retrospective single-center study

scientific article published on 10 October 2018

Clinical features and treatment of 7 Chinese TAFRO syndromes from 96 de novo Castleman diseases: a 10-year retrospective study

scientific article published on 14 January 2020

Decitabine for myelodysplastic syndromes: dose comparison in a real world clinical setting

scientific article published on 08 January 2019

Decitabine improves overall survival in myelodysplastic syndromes-RAEB patients aged ≥60 years and has lower toxicities: Comparison with low-dose chemotherapy

scientific article published on 31 March 2019

Efficacy and safety of early switching to an outpatient therapy model using oral arsenic plus retinoic acid based-regimen in newly diagnosed acute promyelocytic leukemia

scientific article published on 08 June 2019

Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymp

scientific article published on 19 October 2018

High Expression of TET1 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia From Two Cohorts.

scientific article published on 31 January 2018

Homoharringtonine exhibits potent anti-tumor effect and modulates DNA epigenome in acute myeloid leukemia by targeting SP1/TET1/5hmC

scientific article published on 11 April 2019

IDH1R132S -mutated acute lymphoblastic leukaemia resembles Burkitt lymphoma/leukaemia via activating MYC

scientific article published on 21 November 2020

Ibrutinib Suppresses Early Megakaryopoiesis but Enhances Proplatelet Formation

scientific article published on 22 September 2020

Identification of a novel NUP98-RARA fusion transcript as the 14th variant of acute promyelocytic leukemia

scientific article published on 03 April 2020

Improved long-term survival in all Sanz risk patients of newly diagnosed acute promyelocytic leukemia treated with a combination of retinoic acid and arsenic trioxide-based front-line therapy

scientific article published on 03 June 2018

Integrated genomic analysis identifies deregulated JAK/STAT-MYC-biosynthesis axis in aggressive NK-cell leukemia.

scientific article published on 17 November 2017

Leukemia cutis with IDH1, DNMT3A and NRAS mutations conferring resistance to venetoclax plus 5-azacytidine in refractory AML

scientific article published on 25 November 2020

Low expression of ACLY associates with favorable prognosis in acute myeloid leukemia

scientific article published on 10 May 2019

MiR-362-5p as a novel prognostic predictor of cytogenetically normal acute myeloid leukemia

scientific article published on 14 March 2018

Mutation status and burden can improve prognostic prediction of patients with lower-risk myelodysplastic syndromes

scientific article published on 24 December 2019

Outcome of adult T-lymphoblastic lymphoma depends on ALL-type chemotherapy, prognostic factors, and performance of allogeneic hematopoietic stem cell transplantation

scientific article published on 01 July 2018

Platelet integrin αIIbβ3: signal transduction, regulation, and its therapeutic targeting

scientific article published on 07 March 2019

Prognostic utility of six mutated genes for older patients with acute myeloid leukemia.

scientific article published on 29 November 2017

Promising efficacy of novel BTK inhibitor AC0010 in mantle cell lymphoma

scientific article published in February 2018

R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling.

scientific article published on 11 December 2017

RARγ-rearrangements resemble acute promyelocytic leukemia and benefit from 3 + 7 regimen

scientific article published on 11 January 2019

Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy